GEP of the available study [22] confirmed the trend of the immunohistochemical results, with high CSNK2A1, CSNK2A2 and CSNK2B mRNA levels in all the considered lymphoid tumors. The gene discussed is CSNK2A1; the disease is lymphoid neoplasm.